We report the development
of a supramolecular structure endowed
with photosensitizing properties and targeting capability for antimicrobial
photodynamic inactivation. Our synthetic strategy uses the tetrameric
bacterial protein streptavidin, labeled with the photosensitizer eosin,
as the main building block. Biotinylated immunoglobulin G (IgG) from
human serum, known to associate with
Staphylococcus
aureus
protein A, was bound to the complex streptavidin–eosin.
Fluorescence correlation spectroscopy and fluorescence microscopy
demonstrate binding of the complex to
S. aureus
. Efficient photoinactivation is observed for
S. aureus
suspensions treated with IgG–streptavidin–eosin at
concentrations higher than 0.5 μM and exposed to green light.
The proposed strategy offers a flexible platform for targeting a variety
of molecules and microbial species.